Orion Portfolio Solutions, LLC Catalent, Inc. Transaction History

Orion Portfolio Solutions, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $2.18 Million - $2.32 Million	-40,770 Reduced 75.25%	13,406 $753,000
Q1 2024 May 09, 2024	SELL	$42.56 - $59.82 $694,238 - $975,783	-16,312 Reduced 23.14%	54,176 $3.06 Million
Q4 2023 Feb 09, 2024	BUY	$32.18 - $46.57 $336,699 - $487,261	10,463 Added 17.43%	70,488 $3.17 Million
Q3 2023 Nov 01, 2023	SELL	$44.2 - $50.2 $265,730 - $301,802	-6,012 Reduced 9.1%	60,025 $2.73 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $947,994 - $2 Million	-29,755 Reduced 31.06%	66,037 $2.86 Million
Q1 2023 Aug 30, 2023	BUY	$45.44 - $74.26 $1.35 Million - $2.21 Million	29,755 Added 45.06%	95,792 $6.29 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $4.35 Million - $7.11 Million	95,792 New	95,792 $6.29 Million
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $15,057 - $19,147	-207 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$48.02 - $79.04 $8,451 - $13,911	176 Added 567.74%	207 $15,000
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $923 - $1,573	25 Added 416.67%	31 $2,000
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $282 - $339	6 New	6 $0

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.